Get the Stockscreener App
34.06
0.62%
0.21
Pre-market:
35.56
1.50
+4.40%
Surmodics Inc Stock (SRDX) Latest News
Top 3 Health Care Stocks You'll Regret Missing This Month - Benzinga
Ratios in Focus: Analyzing Surmodics, Inc (SRDX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Surmodics' (SRDX) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Surmodics (NASDAQ:SRDX) Posts Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
What is Zacks Research's Estimate for Surmodics Q2 Earnings? - MarketBeat
SurModics (SRDX) Loses -13.87% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Revolutionary Blood Clot Treatment: Surmodics' New Pounce XL System Tackles Larger Arteries - StockTitan
Surmodics (NASDAQ:SRDX) Now Covered by StockNews.com - Defense World
Barrington Research Lowers Earnings Estimates for Surmodics - Defense World
Surmodics (SRDX) Expected to Announce Earnings on Thursday - MarketBeat
Surmodics, Inc. (NASDAQ:SRDX) Sees Large Growth in Short Interest - MarketBeat
Surmodics (NASDAQ:SRDX) Trading Down 5.5%Time to Sell? - MarketBeat
Zacks Research Has Positive Outlook of Surmodics Q2 Earnings - Defense World
Surmodics Stock Down Despite Q1 Earnings Beat, Gross Margin Up - MSN
Zacks Research Increases Earnings Estimates for Surmodics - Defense World
SurModics: Fiscal Q1 Earnings Snapshot - CT Insider
Surmodics Reports Q1 Loss and Strategic Moves - TipRanks
SurModics (SRDX) Reports Q1 Loss, Misses Revenue Estimates - MSN
Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results - BioSpace
Surmodics Earnings Analysis: Q1 Recap - Benzinga
Surmodics Inc. (SRDX) reports earnings - Quartz
Surmodics Inc Reports Q1 FY2025 EPS of $(0.26) and Revenue of $2 - GuruFocus.com
SurModics: Fiscal Q1 Earnings Snapshot -January 30, 2025 at 07:25 am EST - Marketscreener.com
Surmodics' $627M Merger in Focus as New FDA Approval Offsets Revenue Decline - StockTitan
Surmodics (SRDX) to Release Earnings on Thursday - Defense World
Here's Why You Should Add Surmodics Stock to Your Portfolio Now - MSN
Surmodics falls on report about FTC review of GTCR deal - Seeking Alpha
Surmodics (NASDAQ:SRDX) Coverage Initiated by Analysts at StockNews.com - Defense World
JPMorgan Chase & Co. Buys 27,960 Shares of Surmodics, Inc. (NASDAQ:SRDX) - Defense World
After Plunging -10.42% in 4 Weeks, Here's Why the Trend Might Reverse for SurModics (SRDX) - Yahoo Finance
Surmodics drops after report on FTC's view on planned sale to GTCR (SRDX:NASDAQ) - Seeking Alpha
Matterport, Surmodics drop amid news of FTC closed door meeting next week - MSN
Surmodics (SRDX) Shares Cross Below 200 DMA - Nasdaq
Matterport, Surmodics drop amid news of FTC closed door meeting next week (MTTR:NASDAQ) - Seeking Alpha
Surmodics (NASDAQ:SRDX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Surmodics (FRA:SU6) 5-Day RSI : 39.40 (As of Jan. 09, 2025) - GuruFocus.com
AtriCure (NASDAQ:ATRC) versus Surmodics (NASDAQ:SRDX) Head to Head Analysis - Defense World
Jane Street Group LLC Has $522,000 Stock Position in Surmodics, Inc. (NASDAQ:SRDX) - Defense World
5.14%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):